A recent study in Nature Communications introduces a hydrogel (OSPPB) designed to mitigate osteoarthritis (OA) by scavenging extracellular RNA and releasing bevacizumab to inhibit neurovascularization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results